|
R406,
[14C]- |
MC2731 |
|
Raloxifene, hydrochloride |
M 1907 |
| Raloxifene, [3H]- |
MT 1969 |
| Rapamycin |
M 1922 |
|
Rapamycin, [3H]- |
MT 1982 |
| Rebaudioside A, [3H]- |
MT 2037 |
|
Regorafenib, [3H]- |
MT 2082 |
|
Reserpine, [3H]- |
MT 2103 |
| Reserpine, [3,4,5-trimethoxybenzoyl-2-3H]- |
MT 2031 |
|
Resiniferatoxin,
[3H]- |
MT 1768 |
|
Resiquimod, [3H]- |
MT 1898 |
|
Resiquimod, [benzene-3H]- |
MT 1901 |
|
Resveratrol |
M 1606 |
|
Resveratrol, [3H]- |
MT 1606 |
|
Rhodamine 123, [3H]- |
MT 2064 |
| Rhodamine 6G, [3H]- |
MT 1939 |
|
Rhodamine B, [3H]- |
MT 2065 |
| β-D-Ribamidine,
[ribose-13C(U)]- |
MG 134 |
| β-D-Ribamidine, [5-14C]- |
MC 2057 |
|
D-Ribamidine,
[3H]- |
MT 1702 |
|
D-Ribavirin |
M 1736 |
|
Ribavirin,
[5-14C]- |
MC 2011 |
|
D-Ribavirin,
[triazole-5-3H]- |
MT 540 |
|
Ribavirin 5'-monophosphate,
diammonium salt |
M 1601 |
|
Ribavirin 5'-monophosphate,
diammonium salt,
[3H]- |
MT 1601 |
| L-Ribavirin-5'-monophosphate, [3H]- |
MT 1975 |
|
Ribavirin 5'-triphosphate,
tetraammonium salt |
M 1593 |
|
Ribavirin 5'-triphosphate,
tetraammonium salt,
[3H]- |
MT 1593 |
|
Riboflavin, [3H]-
(Vitamin B2, [3H]-) |
MT 605 |
|
1-β-D-Ribofuranosyl-3-ethynyl-[1,2,4]triazole, [5-3H(N)]- |
MT 1896 |
|
1-β-D-Ribofuranosyl-1H-pyrazolo
[3,4-d]-pyrimidine-4-one, [3H]-
(Allopurinol
riboside, [3H]-) |
MT 651 |
|
D-Ribose, [1-14C]- |
MC 2214 |
|
D-Ribose,
[1-3H]-....>
10
Ci/mmol |
MT 1504 |
|
D-Ribose,
[1-3H]-...
4-10 Ci/mmol |
MT 1504L |
|
L-Ribose, [1-14C]- |
MC 2021 |
|
D-Ribose,
[5-3H]-
Discontinued |
MT 541 |
|
Rifampin,
[4-methylpiperazine-3H]- |
MT 1626 |
|
Rifampin,
[4-methylpiperazine-3H]- |
MT 1626M |
|
Rilpivirine,
hydrochloride salt,
[3H]- |
MT 2162 |
|
Riociguat,
[3H]- |
MT 2144 |
|
Ritonavir standard |
M 1535 |
|
Ritonavir,
[3H]- |
MT 1535 |
|
Ritonavir, [L-Valine-14C(U)]- |
MC 2799 |
|
Ro 25-6981, [3H]- |
MT 2117 |
| Roflumilast, [3H]- |
MT 2003 |
|
Rolipram, [methyl-3H]- |
MT 2078 |
| Ropivacaine, hydrochloride salt, [3H]- |
MT 2023 |
| Rosuvastatin, [3H]- |
MT 1942 |
| Rupatadine fumarate, [11-14C]- |
MC 2484 |
|
Ruxolitinib, [3H]- |
MT 2127 |